These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Off-Label Use of Agents for Management of Serious or Life-threatening Angiotensin Converting Enzyme Inhibitor-Induced Angioedema. Culley CM; DiBridge JN; Wilson GL Ann Pharmacother; 2016 Jan; 50(1):47-59. PubMed ID: 26416949 [TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid for ACE inhibitor induced angioedema - A case report. Wang K; Geiger H; McMahon A Am J Emerg Med; 2020 Oct; ():. PubMed ID: 34756369 [TBL] [Abstract][Full Text] [Related]
7. Novel Therapies for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review of Current Evidence. Riha HM; Summers BB; Rivera JV; Van Berkel MA J Emerg Med; 2017 Nov; 53(5):662-679. PubMed ID: 28939396 [TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid for angiotensin converting enzyme inhibitor induced angioedema: A retrospective multicenter study. Lindauer KE; Lo BM; Weingart GS; Karpov MV; Gartman GH; Neubauer LE; Kaplan MC Am J Emerg Med; 2024 May; 79():33-37. PubMed ID: 38340480 [TBL] [Abstract][Full Text] [Related]
9. Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema. Fok JS; Katelaris CH; Brown AF; Smith WB Intern Med J; 2015 Aug; 45(8):821-7. PubMed ID: 25944565 [TBL] [Abstract][Full Text] [Related]
10. Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: A meta-analysis of randomized controlled trials. Jeon J; Lee YJ; Lee SY J Clin Pharm Ther; 2019 Oct; 44(5):685-692. PubMed ID: 31290163 [TBL] [Abstract][Full Text] [Related]
11. Pharmacologic management of angioedema induced by angiotensin-converting enzyme inhibitors. Scalese MJ; Reinaker TS Am J Health Syst Pharm; 2016 Jun; 73(12):873-9. PubMed ID: 27261237 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Treatment of Non-hereditary Angioedema. van den Elzen M; Go MFCL; Knulst AC; Blankestijn MA; van Os-Medendorp H; Otten HG Clin Rev Allergy Immunol; 2018 Jun; 54(3):412-431. PubMed ID: 27672078 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department. Bernstein JA; Moellman JJ; Collins SP; Hart KW; Lindsell CJ Ann Allergy Asthma Immunol; 2015 Mar; 114(3):245-9. PubMed ID: 25601538 [TBL] [Abstract][Full Text] [Related]
14. Angioedema: etiology, pathophysiology, current and emerging therapies. Lewis LM J Emerg Med; 2013 Nov; 45(5):789-96. PubMed ID: 23992848 [TBL] [Abstract][Full Text] [Related]
15. [Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors]. Beauchêne C; Martins-Héricher J; Denis D; Martin L; Maillard H Rev Med Interne; 2018 Oct; 39(10):772-776. PubMed ID: 29735174 [TBL] [Abstract][Full Text] [Related]
16. ACE inhibitor-mediated angioedema. Montinaro V; Cicardi M Int Immunopharmacol; 2020 Jan; 78():106081. PubMed ID: 31835086 [TBL] [Abstract][Full Text] [Related]
18. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. Blais C; Rouleau JL; Brown NJ; Lepage Y; Spence D; Munoz C; Friborg J; Geadah D; Gervais N; Adam A Immunopharmacology; 1999 Sep; 43(2-3):293-302. PubMed ID: 10596866 [TBL] [Abstract][Full Text] [Related]
19. Recognition and Differential Diagnosis of Hereditary Angioedema in the Emergency Department. Pines JM; Poarch K; Hughes S J Emerg Med; 2021 Jan; 60(1):35-43. PubMed ID: 33218838 [TBL] [Abstract][Full Text] [Related]
20. Treatment of ACEI-related angioedema with icatibant: a case series. Bova M; Guilarte M; Sala-Cunill A; Borrelli P; Rizzelli GM; Zanichelli A Intern Emerg Med; 2015 Apr; 10(3):345-50. PubMed ID: 25666515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]